Medella Springs, a wellness brand focused on nature-inspired supplements and whole-body support, is helping families navigate the growing conversation around focus, attention, and daily cognitive wellness with AddiVance, a drug-free, non-stimulant...
pathogens in a single test. A core feature of Seegene's syndromic real-time PCR technology is its ability to detect up to 14 pathogens that cause similar signs and symptoms in a single tube while providing quantitative information to support more...
more confidently in their daily routine, while building on the trusted performance associated with the CONTOUR® brand.” 1 CONTOUR COMFORT pen needles have been developed to support ease of use in daily therapy. They combine advanced 5-bevel tip...
Administration (FDA) has approved XOCOVA® (ensitrelvir), an oral antiviral, for post-exposure prophylaxis (PEP) of COVID‑19 in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19.3 This approval...
in combination with doxorubicin, vinblastine and dacarbazine (AVD) for the treatment of adult and adolescent patients 12 years of age and older with previously untreated Stage III or IV classical Hodgkin Lymphoma (cHL). This approval marks a...
mutated and non-BRCA HRR gene-mutated mCRPC. Prostate cancer is the second most common cancer in men, with approximately 1 in 8 diagnosed during their lifetime.2 mCRPC occurs when prostate cancer grows and spreads to other parts of the body despite...
program has generated valuable insights into ALS disease biology, including pharmacogenomic response associated with the UNC13A genotype, biomarker data collected at seven longitudinal time points, and a comprehensive analysis of the "Floor Effect"...
product (LBP) indicated in the United States to prevent recurrent Clostridioides difficile infection (rCDI) in individuals 18 years of age and older following antibacterial treatment for rCDI. Under the agreement, the parties will work jointly to...
Ori’s IRO® platform. The IIT is aiming to evaluate ImmuXell’s TCR-T therapy in patients with solid tumors harboring KRAS G12V mutations, including those with colorectal cancer, pancreatic cancer, and lung cancer — all among the deadliest and most...
project represents a major government-led initiative with a total investment of approximately US$260 million over the next 10 years. Under the framework, VECOL has been designated by the Colombian government as the lead implementing entity...
genetically confirmed HoFH completed the 72-week, open-label, extension study, with mean and absolute LDL-C reductions of 19.1% and 1.44 mmol/L (55.7 mg/dL), respectively, at the 72-week primary endpoint. At week 72, mean ApoB was reduced by 12.7%...
The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...
and sensitivity to light and sound. Migraine affects one in seven people and is a leading cause of disability worldwide.1 Approximately 11% of the population in Korea currently lives with migraine, a figure that may be underestimated.1,2 Despite...
therapy beyond five years.2,3 More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new analysis of the ongoing BCI Registry Study, which evaluates how physicians incorporate prognostic...
a biotechnology company developing first-in-class therapies targeting cancer stem cells, announced that its second ADAR1p150 protein crystallization experiment has successfully launched aboard the SpaceX CRS-34 commercial resupply mission to the...
(PEF) therapies for oncology and chronic lung disease, today announced that it received U.S. Food and Drug Administration 510(k) clearance for the Aliya® EX Generator for surgical ablation of soft tissue. The Aliya EX Generator expands the Aliya...
announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1. Menziuso brings more than 30 years of global healthcare leadership experience and a strong track record of driving growth...
that re-induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) resulted in complete responses (CR) in approximately 31% (4/13) of patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC)...
the skin's intrinsic longevity pathways to visibly restore firmness, smoothness, and overall skin health." clinical claims 100% saw skin that looked lifted, deeply replenished, and more even-toned* *Results after 8 weeks. Based on a consumer...
Pathobiology 2026 – May 16-19, 2026, in Fort Myers, Florida. Similar to the past two Annual Meetings, Pathobiology 2026 will be a stand-alone meeting that will leverage our society’s unique strengths in the understanding of cellular and molecular...
